Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.

Derek Law; Caroline B. Moore; David W. Denning

doi:DOI: 10.1128/AAC.41.10.2310

Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.

Derek Law
, Caroline B. Moore
, David W. Denning^*

^*Corresponding author for this work

Division of Immunology, Immunity to Infection and Respiratory Medicine

Hope Hospital Salford Royal NHS Foundation Trust
Hyder Environmental

Research output: Contribution to journal › Article › peer-review

Abstract

The in vitro activity of Schering 56592, a new azole drug, was compared with those of fluconazole and itraconazole against 103 isolates of Candida comprising 10 different species. Schering 56592 was more active than itraconazole and fluconazole, and it was active against many fluconazole- resistant isolates.

Original language	English
Pages (from-to)	2310-2511
Number of pages	202
Journal	Antimicrobial Agents and Chemotherapy
Volume	41
Issue number	10
DOIs	https://doi.org/DOI: 10.1128/AAC.41.10.2310
Publication status	Published - 1 Oct 1997

Access to Document

DOI: 10.1128/AAC.41.10.2310Licence: Unspecified

Cite this

@article{2006955f0eda49f393d1150d81720f61,

title = "Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.",

abstract = "The in vitro activity of Schering 56592, a new azole drug, was compared with those of fluconazole and itraconazole against 103 isolates of Candida comprising 10 different species. Schering 56592 was more active than itraconazole and fluconazole, and it was active against many fluconazole- resistant isolates.",

author = "Derek Law and Moore, \{Caroline B.\} and Denning, \{David W.\}",

year = "1997",

month = oct,

day = "1",

doi = "DOI: 10.1128/AAC.41.10.2310",

language = "English",

volume = "41",

pages = "2310--2511",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "10",

}

TY - JOUR

T1 - Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.

AU - Law, Derek

AU - Moore, Caroline B.

AU - Denning, David W.

PY - 1997/10/1

Y1 - 1997/10/1

N2 - The in vitro activity of Schering 56592, a new azole drug, was compared with those of fluconazole and itraconazole against 103 isolates of Candida comprising 10 different species. Schering 56592 was more active than itraconazole and fluconazole, and it was active against many fluconazole- resistant isolates.

AB - The in vitro activity of Schering 56592, a new azole drug, was compared with those of fluconazole and itraconazole against 103 isolates of Candida comprising 10 different species. Schering 56592 was more active than itraconazole and fluconazole, and it was active against many fluconazole- resistant isolates.

UR - https://www.scopus.com/pages/publications/0030821205

U2 - DOI: 10.1128/AAC.41.10.2310

DO - DOI: 10.1128/AAC.41.10.2310

M3 - Article

C2 - 9333073

AN - SCOPUS:0030821205

SN - 0066-4804

VL - 41

SP - 2310

EP - 2511

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 10

ER -

Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp.

Abstract

Access to Document

Other files and links

Fingerprint

Cite this